Skip Navigation



BJA Advance Access published online on April 4, 2006

British Journal of Anaesthesia, doi:10.1093/bja/ael082
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
96/6/694    most recent
ael082v1
Right arrow E-Letters: Submit a response to the article
Right arrow E-letters: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tritapepe, L.
Right arrow Articles by Pietropaoli, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tritapepe, L.
Right arrow Articles by Pietropaoli, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Board of Management and Trustees of the British Journal of Anaesthesia 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Accepted March 7, 2006

Clinical Investigation

Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study

L. Tritapepe 1, V. De Santis 1 *, D. Vitale 1, M. Santulli 2, A. Morelli 1, I. Nofroni 3, P. E. Puddu 4, M. Singer 5 {dagger}, and P. Pietropaoli 1

1 Department of Anesthesiology and Intensive Care, University of Rome ‘La Sapienza’, Rome, Italy
2 Department of Cellular Biotechnology and Haematology, University of Rome ‘La Sapienza’, Rome, Italy
3 Department of Experimental Medicine and Pathology, University of Rome ‘La Sapienza’, Rome, Italy
4 VOC di Biotecnologie Applicate alle Malattie Cardiovasculari, Department of the Heart and Great Vessels ‘Attilio Reale’, University of Rome ‘La Sapienza’, Rome, Italy
5 Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK

* To whom correspondence should be addressed.
V. De Santis, E-mail: vincenzo.desantis{at}uniroma1.it


   Abstract

Background. The calcium sensitizer levosimendan protects against myocardial ischaemia and reperfusion injury in animal models.

Methods. The present pilot study investigated whether a short infusion before coronary artery bypass grafting (CABG) would protect the myocardium and improve postoperative haemodynamics. Twenty-four patients with stable angina undergoing elective CABG surgery were randomized to receive either placebo or levosimendan (24 µg kg-1) infused i.v. over a 10 min period just before placing the patient on cardiopulmonary bypass.

Results. Perioperative haemodynamic variables, concentrations of cardiac troponin I over the 48 h postoperative period, and clinical outcomes were assessed. There were no adverse effects related to levosimendan. Compared with control patients, levosimendan-treated patients had lower postoperative troponin I concentrations (P<0.05) and a higher cardiac index (P<0.05).

Conclusion. Patients receiving a short infusion of levosimendan before CABG showed evidence of less myocardial damage, suggestive of a preconditioning effect. Larger outcome studies are thus indicated to confirm benefit.

Keywords: anaesthesia, cardiac; complications, myocardial infarction; heart, ischaemia; heart, myocardial function; muscle cardiac, contractility.
{dagger}Declaration of interest. M.S. has sat on advisory boards for levosimendan on behalf of Orion, the manufacturer, and Abbott, the distributor. He has also received honoraria for chairing/speaking at satellite symposia and for co-editing a website, failinghears.com, supported by an unrestricted educational grant from Abbott.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
N. Mongardon, A. Dyson, and M. Singer
Pharmacological optimization of tissue perfusion
Br. J. Anaesth., July 1, 2009; 103(1): 82 - 88.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
V. Venugopal, A. Ludman, D. M. Yellon, and D. J. Hausenloy
'Conditioning' the heart during surgery
Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 977 - 987.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. I. Eriksson, J. R. Jalonen, L. O. Heikkinen, M. Kivikko, M. Laine, K. A. Leino, A. H. Kuitunen, K. T. Kuttila, T. K. Perakyla, T. Sarapohja, et al.
Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function.
Ann. Thorac. Surg., February 1, 2009; 87(2): 448 - 454.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
L. Tritapepe, V. De Santis, D. Vitale, F. Guarracino, F. Pellegrini, P. Pietropaoli, and M. Singer
Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery
Br. J. Anaesth., February 1, 2009; 102(2): 198 - 204.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. S. Pagel
Levosimendan in Cardiac Surgery: A Unique Drug for the Treatment of Perioperative Left Ventricular Dysfunction or Just Another Inodilator Searching for a Clinical Application?
Anesth. Analg., April 1, 2007; 104(4): 759 - 761.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. G. De Hert, S. Lorsomradee, S. Cromheecke, and P. J. Van der Linden
The Effects of Levosimendan in Cardiac Surgery Patients with Poor Left Ventricular Function
Anesth. Analg., April 1, 2007; 104(4): 766 - 773.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
S. Kumar, A. Kumar, and V. De Santis
The preconditioning effects of levosimendan.
Br. J. Anaesth., September 1, 2006; 97(3): 425 - 425.
[Full Text] [PDF]

E-letters:

Read all E-letters

MIP: Many questions unanswered.
Dr Sumit Kumar Jha, et al.
British Journal of Anaesthesia, 18 May 2006 [Full text]
Re: MIP: Many questions unanswered.
Vincenzo De Santis
British Journal of Anaesthesia, 31 May 2006 [Full text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.